Author： Wigley F.M. Sule S.D.
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.1, 2001-01, pp. : 31-48
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Emerging targets for the treatment of scleroderma
By Leask Andrew
Expert Opinion on Emerging Drugs, Vol. 17, Iss. 2, 2012-06 ,pp. :
Access to resources
Recommend
Treatment of scleroderma: an update
By Sule Sangeeta D Wigley Fredrick M
Expert Opinion on Investigational Drugs, Vol. 12, Iss. 3, 2003-03 ,pp. :
Scleroderma Lung: Pathogenesis, Evaluation and Current Therapy
Drugs, Vol. 67, Iss. 7, 2007-01 ,pp. :
Micro- and Macrovascular Treatment Targets in Scleroderma Heart Disease
Current Pharmaceutical Design, Vol. 20, Iss. 4, 2014-02 ,pp. :